Asiri Hospital Holdings PLC

  • Market Cap: Large Cap
  • Industry: Hospital
  • ISIN: LK0010N00005
LKR
33.90
0.8 (2.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Operating profit has grown by an annual rate 27.47% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has been able to generate a Return on Capital Employed (avg) of 14.52% signifying low profitability per unit of total capital (equity and debt)
2

Poor long term growth as Operating profit has grown by an annual rate 27.47% of over the last 5 years

 
3

Positive results in Dec 25

4

With ROE of 13.94%, it has a very attractive valuation with a 1.56 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

LKR 38,449 Million (Large Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.75

stock-summary
Return on Equity

20.61%

stock-summary
Price to Book

1.65

Revenue and Profits:
Net Sales:
8,864 Million
(Quarterly Results - Dec 2025)
Net Profit:
1,349 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.65%
0%
8.65%
6 Months
-7.12%
0%
-7.12%
1 Year
30.38%
0%
30.38%
2 Years
46.12%
0%
46.12%
3 Years
30.89%
0%
30.89%
4 Years
-20.98%
0%
-20.98%
5 Years
30.38%
0%
30.38%

Asiri Hospital Holdings PLC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
18.30%
EBIT Growth (5y)
27.47%
EBIT to Interest (avg)
2.33
Debt to EBITDA (avg)
2.69
Net Debt to Equity (avg)
0.83
Sales to Capital Employed (avg)
0.75
Tax Ratio
37.64%
Dividend Payout Ratio
103.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.52%
ROE (avg)
15.89%

Valuation key factors

Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
1.56
EV to EBIT
8.94
EV to EBITDA
7.19
EV to Capital Employed
1.32
EV to Sales
1.71
PEG Ratio
2.85
Dividend Yield
NA
ROCE (Latest)
14.78%
ROE (Latest)
13.94%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 4.04% vs -2.29% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 22.63% vs -10.29% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,864.20",
          "val2": "8,520.20",
          "chgp": "4.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,401.50",
          "val2": "2,134.00",
          "chgp": "12.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "429.90",
          "val2": "522.10",
          "chgp": "-17.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,349.00",
          "val2": "1,100.10",
          "chgp": "22.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "214.00%",
          "val2": "190.80%",
          "chgp": "2.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.58% vs 15.27% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 1,657.94% vs -106.90% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31,022.10",
          "val2": "28,571.50",
          "chgp": "8.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,119.50",
          "val2": "4,756.70",
          "chgp": "28.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2,006.50",
          "val2": "3,585.20",
          "chgp": "-44.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,825.90",
          "val2": "-117.20",
          "chgp": "1,657.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "133.80%",
          "val2": "99.20%",
          "chgp": "3.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
8,864.20
8,520.20
4.04%
Operating Profit (PBDIT) excl Other Income
2,401.50
2,134.00
12.54%
Interest
429.90
522.10
-17.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,349.00
1,100.10
22.63%
Operating Profit Margin (Excl OI)
214.00%
190.80%
2.32%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.04% vs -2.29% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 22.63% vs -10.29% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
31,022.10
28,571.50
8.58%
Operating Profit (PBDIT) excl Other Income
6,119.50
4,756.70
28.65%
Interest
2,006.50
3,585.20
-44.03%
Exceptional Items
0.50
0.00
Consolidate Net Profit
1,825.90
-117.20
1,657.94%
Operating Profit Margin (Excl OI)
133.80%
99.20%
3.46%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 8.58% vs 15.27% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 1,657.94% vs -106.90% in Mar 2024

stock-summaryCompany CV
About Asiri Hospital Holdings PLC stock-summary
stock-summary
Asiri Hospital Holdings PLC
Hospital
Asiri Hospital Holdings PLC is engaged in providing healthcare and hospital services. The Company operates a hospital, provides healthcare services, and manages and holds investments in the healthcare industry. The Company provides its tests in various areas, such as chemical pathology, biochemistry, clinical pathology, hematology, microbiology, histology and immunology. The Company offers various services, which include critical care wards, neonatal intensive care unit, dialysis unit, operating theaters, intensive care unit, e-channeling consultation, emergency medical service unit, ultrasound scanning, echocardiography with two dimension (2D) Doppler analysis, pharmacy, mobile electrocardiogram, mobile laboratory service, X-ray with image intensifying and screening facilities, stress echocardiography and periodic medical check-up scheme. Its subsidiaries include Asiri Central Hospitals Ltd., Asiri Hospital Matara (Pvt) Ltd and Hemas Southern Hospitals (Private) Limited.
Company Coordinates stock-summary
Company Details
181, Kirula Road, Colombo 5 , COLOMBO None : 05
Registrar Details